DexCom Director Euan A. Ashley Transfers 2,389 Shares to Family Trust
DEXCOM INC
Subscribe to track DXCM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 SEC Form 4 Filing: DEXCOM INC ($DXCM) Insider: Ashley Euan A. (Director) Transaction Date: 2026-10-30 Type: Gift / Estate Transfer (Code G) Shares: 2,389 @ $0.00 Total Value: $0 Shares Remaining (Direct): 10,342 Indirect Holdings (Trust): 2,389 Trading Significance: Low (Transfer to Revocable Living Trust)
Comprehensive Analysis
Executive Summary
On November 3, 2026, DexCom, Inc. ($DXCM) board member Dr. Euan A. Ashley filed a Form 4 disclosing a transaction dated October 30, 2026. The transaction involves the transfer of 2,389 shares of common stock to the Ashley Family Revocable Living Trust for no consideration (gift/transfer, Code G).
Transaction Details
- Insider: Euan A. Ashley (Director)
- Security: Common Stock
- Transaction Code: G (Bona fide gift / transfer without consideration)
- Shares Disposed (Direct): 2,389
- Price per Share: $0.00
- Post-Transaction Holdings:
- Direct: 10,342 shares (consisting of unvested RSUs)
- Indirect: 2,389 shares held by the Ashley Family Revocable Living Trust, of which the reporting person and spouse are co-trustees.
Market & Governance Impact
This filing reflects routine personal estate planning rather than an open-market sale or purchase. Dr. Ashley maintains beneficial ownership of the transferred shares through the trust. Consequently, this transaction carries low trading significance and implies no directional sentiment regarding DexCom's business outlook.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.